Our studies have demonstrated that SNX12 may participate in AD pathology by interacting with BACE1, thereby regulating BACE1 intracellular trafficking and BACE1-mediated β-processing of APP in Aβ production. The gene discussed is SNX12; the disease is Alzheimer disease.